LHRH Agonist: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
2
Conditions studied
30
US states with sites
37
Countries
Phase breakdown
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Breast Cancer | 2 |
| Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 1 |
Recruiting trials involving LHRH Agonist
- A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
- Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Common questions
How many recruiting trials involve LHRH Agonist?
2 recruiting trials across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.